SEC Form 4 · accession 0001104659-16-141736
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Shkreli
10% Owner
Period of report
Aug 25, 2016
Accepted (ET)
Aug 29, 2016 · 6:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 25, 2016 | S | 1,913,206 | $3.10 | D | 309,723 | D | |
| Common StockF1 | Aug 26, 2016 | S | 309,723 | $3.10 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 25, 2016 and August 26, 2016, Martin Shkreli sold all 1,913,206 shares of Common Stock of Kalobios Pharmaceuticals, Inc. that he then beneficially owned in private transactions.